Q BioMed Announces Strontium89 Initial Uptake and Momentum in US and EuropeSeveral International Market Authorisations Expected in Q4 Expanding Access to South and Central America and...
Q BioMed Announces Initiation of GMP Production of Novel COVID-19 Therapeutic for Clinical Trial Program COVID-19 clinical trial planned for Q1 2021 supported by Canadian...
Q BioMed Announces Strontium89 will be available as of September 2020 through Named Patient Program for Bone Metastases Pain Palliation in EU and Rest of World Named Patient...
FORT LEE, NJ -- March 19, 2019 -- InvestorsHub NewsWire -- GD Entertainment And Technology (OTC: GDET) (“GDET” or the “Company”) today announced CEO Anil Idnani was...
Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements Coral Springs, FL -- July 27, 2016 -- InvestorsHub...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 1.0E-6 | 1.0E-6 | 1.0E-6 | 6263 | 1.0E-6 | CS |
4 | -9.9E-5 | -99 | 0.0001 | 0.0001 | 1.0E-6 | 29425 | 3.169E-5 | CS |
12 | 0 | 0 | 1.0E-6 | 0.0001 | 1.0E-6 | 162767 | 9.094E-5 | CS |
26 | -0.000399 | -99.75 | 0.0004 | 0.0005 | 1.0E-6 | 108605 | 9.491E-5 | CS |
52 | -0.000499 | -99.8 | 0.0005 | 0.0405 | 1.0E-6 | 70534 | 0.0001074 | CS |
156 | -0.399999 | -99.99975 | 0.4 | 0.575 | 1.0E-6 | 648592 | 0.02642877 | CS |
260 | -1.819999 | -99.9999450549 | 1.82 | 3.75 | 1.0E-6 | 390998 | 0.17322646 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.